Cargando…

Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2

The Polycomb repressive complex 2 (PRC2) is a conserved chromatin-remodelling complex that catalyses the trimethylation of histone H3 lysine 27 (H3K27me3), a mark associated with gene silencing. PRC2 regulates chromatin structure and gene expression during organismal and tissue development and tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngubo, Mzwanele, Moradi, Fereshteh, Ito, Caryn Y., Stanford, William L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606531/
https://www.ncbi.nlm.nih.gov/pubmed/37895228
http://dx.doi.org/10.3390/genes14101879
_version_ 1785127338541842432
author Ngubo, Mzwanele
Moradi, Fereshteh
Ito, Caryn Y.
Stanford, William L.
author_facet Ngubo, Mzwanele
Moradi, Fereshteh
Ito, Caryn Y.
Stanford, William L.
author_sort Ngubo, Mzwanele
collection PubMed
description The Polycomb repressive complex 2 (PRC2) is a conserved chromatin-remodelling complex that catalyses the trimethylation of histone H3 lysine 27 (H3K27me3), a mark associated with gene silencing. PRC2 regulates chromatin structure and gene expression during organismal and tissue development and tissue homeostasis in the adult. PRC2 core subunits are associated with various accessory proteins that modulate its function and recruitment to target genes. The multimeric composition of accessory proteins results in two distinct variant complexes of PRC2, PRC2.1 and PRC2.2. Metal response element-binding transcription factor 2 (MTF2) is one of the Polycomb-like proteins (PCLs) that forms the PRC2.1 complex. MTF2 is highly conserved, and as an accessory subunit of PRC2, it has important roles in embryonic stem cell self-renewal and differentiation, development, and cancer progression. Here, we review the impact of MTF2 in PRC2 complex assembly, catalytic activity, and spatiotemporal function. The emerging paradoxical evidence suggesting that MTF2 has divergent roles as either a tumour suppressor or an oncogene in different tissues merits further investigations. Altogether, our review illuminates the context-dependent roles of MTF2 in Polycomb group (PcG) protein-mediated epigenetic regulation. Its impact on disease paves the way for a deeper understanding of epigenetic regulation and novel therapeutic strategies.
format Online
Article
Text
id pubmed-10606531
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106065312023-10-28 Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2 Ngubo, Mzwanele Moradi, Fereshteh Ito, Caryn Y. Stanford, William L. Genes (Basel) Review The Polycomb repressive complex 2 (PRC2) is a conserved chromatin-remodelling complex that catalyses the trimethylation of histone H3 lysine 27 (H3K27me3), a mark associated with gene silencing. PRC2 regulates chromatin structure and gene expression during organismal and tissue development and tissue homeostasis in the adult. PRC2 core subunits are associated with various accessory proteins that modulate its function and recruitment to target genes. The multimeric composition of accessory proteins results in two distinct variant complexes of PRC2, PRC2.1 and PRC2.2. Metal response element-binding transcription factor 2 (MTF2) is one of the Polycomb-like proteins (PCLs) that forms the PRC2.1 complex. MTF2 is highly conserved, and as an accessory subunit of PRC2, it has important roles in embryonic stem cell self-renewal and differentiation, development, and cancer progression. Here, we review the impact of MTF2 in PRC2 complex assembly, catalytic activity, and spatiotemporal function. The emerging paradoxical evidence suggesting that MTF2 has divergent roles as either a tumour suppressor or an oncogene in different tissues merits further investigations. Altogether, our review illuminates the context-dependent roles of MTF2 in Polycomb group (PcG) protein-mediated epigenetic regulation. Its impact on disease paves the way for a deeper understanding of epigenetic regulation and novel therapeutic strategies. MDPI 2023-09-27 /pmc/articles/PMC10606531/ /pubmed/37895228 http://dx.doi.org/10.3390/genes14101879 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ngubo, Mzwanele
Moradi, Fereshteh
Ito, Caryn Y.
Stanford, William L.
Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
title Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
title_full Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
title_fullStr Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
title_full_unstemmed Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
title_short Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
title_sort tissue-specific tumour suppressor and oncogenic activities of the polycomb-like protein mtf2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606531/
https://www.ncbi.nlm.nih.gov/pubmed/37895228
http://dx.doi.org/10.3390/genes14101879
work_keys_str_mv AT ngubomzwanele tissuespecifictumoursuppressorandoncogenicactivitiesofthepolycomblikeproteinmtf2
AT moradifereshteh tissuespecifictumoursuppressorandoncogenicactivitiesofthepolycomblikeproteinmtf2
AT itocaryny tissuespecifictumoursuppressorandoncogenicactivitiesofthepolycomblikeproteinmtf2
AT stanfordwilliaml tissuespecifictumoursuppressorandoncogenicactivitiesofthepolycomblikeproteinmtf2